"Coronavirus/COVID19: Information til patienter, pårørende og gæster på Sygehus Sønderjylland findes på sygehusets hjemmeside. ______________ Sygehus Sønderjylland er ét samlet sygehus med adresser og aktiviteter på tre forskellige matrikler: I Aabenraa modtager vi fortrinsvis akut syge eller tilskadekomne patienter samt børn, unge, gravide og fødende. I Sønderborg har vi i vid udstrækning patienter, som får foretaget planlagte sammedagskirurgiske indgreb eller behandling og kontrol for kroniske lidelser. På sygehuset i Tønder er vi specialiseret i at udrede patienterne og lægge en plan for behandling samme dag. I alle tre byer behandler vi tilskadekomne med behov for akuthjælp, og vi har ambulante behandlings- og undersøgelsestilbud."

During the past decade, Hospital of Southern Jutland conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 2 clinical trials were completed, i.e. on average, 6.9% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital of Southern Jutland" #1 sponsor was "University of Southern Denmark" with 23 trials, followed by "Pfizer" with 2 trials sponsored, "Henrik Wiggers" with 1 trials sponsored, "Herlev Hospital" with 1 trials sponsored and "Karolinska Institutet" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital of Southern Jutland" #1 collaborator was "Hospital of Southern Jutland" with 4 trials as a collaborator, "Odense University Hospital" with 4 trials as a collaborator, "Aalborg University Hospital" with 3 trials as a collaborator, "Aarhus University Hospital" with 3 trials as a collaborator and "Bispebjerg Hospital" with 2 trials as a collaborator. Other collaborators include 64 different institutions and companies that were collaborators in the rest 62 trials.

According to Clinical.Site data, the most researched conditions in "Hospital of Southern Jutland" are "Acute Pyelonephritis" (2 trials), "Breast Cancer" (2 trials), "Cardiovascular Disease" (2 trials), "Coronary Artery Disease" (2 trials) and "Inflammatory Bowel Diseases" (2 trials). Many other conditions were trialed in "Hospital of Southern Jutland" in a lesser frequency.

Most popular intervention types in "Hospital of Southern Jutland" are "Diagnostic Test" (9 trials), "Drug" (8 trials), "Other" (8 trials), "Procedure" (5 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Other (exploratory) exposure variables" (2 trials), "Primary exposure variable" (2 trials), "Standard care" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital of Southern Jutland" are 30 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital of Southern Jutland". undefined are not yet recruiting, 8 are recruiting, 3 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 17 completed trials in Hospital of Southern Jutland, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital of Southern Jutland, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 10 trials that are defined as “Not Applicable".